What is CaNCURE?

CaNCURE was created in 2015 to provide Northeastern University undergrads with experiential training in cancer nanomedicine.  Sixty-six trainees have already completed the program so far, and we expect to train another eighty-nine students in the next 5 years.
Our co-op students spend 6-months performing hands-on research in a NCI-funded research laboratory.   This research experience is supplemented with research and bio/nano innovation seminars, professional development activities, and opportunities to present research.
Our alumni have successfully found new co-op and jobs in cancer research, scholarships to medical school, and scholarships to graduate school.  58% of alumni are currently performing cancer research.

75

Trainees

29

Mentors

31

Publications

118

Presentations


Hear from our Alumni:

“Due to both the helpfulness of my lab members and the weekly CaNCURE seminars, I have gained a strong understanding of my research and see the possible applications of this work in the cancer nanomedicine industry. CaNCURE has provided an all-encompassing co-op experience, helping me not only to see the implications of the research with which I’m involved, but also how to extend these ideas based on my own knowledge.”

Sonali Rodrigues, Behavioral Neuroscience, ’16


Trainee Spotlight


Marina Yamada

Health Science, '21

Triple-targeted Photonanomedicine: A Strategy to Treat Heterogeneous Tumors

Hannah Curtis

Health Science, '21

The Role of CD8+ and CD4+ in the Tumor Microenvironment (TME) after Controlled Exercise in E0771/M3C Breast Cancer Models

Claire Buxton

Molecular Biology, '21

Role of ESRP1/ESRP2 splicing regulators in the development of Triple-Negative Breast Cancer

Featured Trainee Publication


Upcoming Events

Check back soon for new events


Mentor Spotlight


Zdravka Medarova, Ph.D.

Associate Professor in Radiology, MGH/MIT/HMS

The focus of my research has been the development and testing of multi-functional imaging/delivery vehicles for combined cancer imaging and therapy. More recently, our lab developed magnetic nanoparticles as delivery vehicles of miRNA-targeted therapy to breast tumors.


Umar Mahmood, M.D.

Vice Chair for Precision Imaging, Department of Radiology,

Develops molecular imaging tools for cancer treatment and treatment monitoring. Students will have the opportunity to create and validate new imaging probes, develop cell and animal models with clinically relevant pathologies, and aid in the clinical translation of successful technologies.


Trainee Spotlight


Claire Buxton

Molecular Biology, '21

Role of ESRP1/ESRP2 splicing regulators in the development of Triple-Negative Breast Cancer

Rodrigo Blanco Bravo

Bioengineering, '22

Multiplexed cellular fluorescent imaging in head and neck squamous cell carcinomas (HNSCC) for different markers to predict patient specific response rates to immunotherapy and for mapping of the tumor microenvironment (TME).

Kevin Lin

Health Science, '21

Granzyme B Peptide as a Non-invasive Theranostic Agent


 Get Involved

Interested in learning how nanomedicine is used to detect and treat cancer? Want to get involved in developing new nanotechnologies for the clinic? We are looking to match undergrads at Northeastern University with leading Boston researchers and clinicians for a six-month, hands-on research experience.  If you are thinking about a career in cancer science, engineering, or medicine, come get involved in the world’s first undergraduate program in cancer nanomedicine!  We have 9 upcoming openings for the January – June 2019 co-op period.  We will be accepting applications starting in September 2018 via NUcareers.

Going on in the lab right now...